Literature DB >> 15504047

Dynamic motions of CD39 transmembrane domains regulate and are regulated by the enzymatic active site.

Alison Grinthal1, Guido Guidotti.   

Abstract

The two transmembrane domains flanking the active site of CD39 regulate its activity, but little is known about the structural and dynamic features underlying their importance. Here we use a disulfide crosslinking strategy to examine transmembrane helix interactions and dynamics and to correlate these features with activity and substrate binding. We find strong intrasubunit TM1-TM2 interactions, as well as TM1-TM1' and TM2-TM2' interactions between dimer subunits, near the extracellular side of the membrane but only weak interactions near the cytoplasmic end. The specific helix faces that constitute each interface are highly flexible, indicating a significant degree of rotational mobility within the packed structure. Analysis of activity after locking the helices in various orientations via disulfide bonds suggests that not only the arrangement but also the ability of the helices to move relative to each other is crucial for enzyme function. Helix mobility is in turn modulated by substrate binding. These results suggest that rather than playing a static structural role to support an optimal active site conformation, the transmembrane domains undergo dynamic motions that underlie their functional relationship with the active site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504047     DOI: 10.1021/bi048644x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Bilayer mechanical properties regulate the transmembrane helix mobility and enzymatic state of CD39.

Authors:  Alison Grinthal; Guido Guidotti
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

2.  Various N-glycoforms differentially upregulate E-NTPDase activity of the NTPDase3/CD39L3 ecto-enzymatic domain.

Authors:  Alexander H Zhong; Z Gordon Jiang; Richard D Cummings; Simon C Robson
Journal:  Purinergic Signal       Date:  2017-09-27       Impact factor: 3.765

3.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

Review 4.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

5.  Proline residues link the active site to transmembrane domain movements in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3).

Authors:  Keith J Gaddie; Terence L Kirley
Journal:  Purinergic Signal       Date:  2010-03-30       Impact factor: 3.765

6.  Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling.

Authors:  Matthias Zebisch; Norbert Sträter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

Review 7.  Possible effects of microbial ecto-nucleoside triphosphate diphosphohydrolases on host-pathogen interactions.

Authors:  Fiona M Sansom; Simon C Robson; Elizabeth L Hartland
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

8.  Interactions between the transmembrane domains of CD39: identification of interacting residues by yeast selection.

Authors:  Sari Paavilainen; Guido Guidotti
Journal:  ScienceOpen Res       Date:  2014

9.  Conserved polar residues stabilize transmembrane domains and promote oligomerization in human nucleoside triphosphate diphosphohydrolase 3.

Authors:  Keith J Gaddie; Terence L Kirley
Journal:  Biochemistry       Date:  2009-10-13       Impact factor: 3.162

10.  Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion.

Authors:  Mei Lin Z Bissonnette; Jason E Donald; William F DeGrado; Theodore S Jardetzky; Robert A Lamb
Journal:  J Mol Biol       Date:  2008-12-24       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.